Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro

Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro
复制标题

DOI:
10.1016/j.lfs.2011.04.025
复制
发表时间:
2011-07-04
期刊:
影响因子:
6.1
通讯作者:
Gjomarkaj, Mark
Gjomarkaj, Mark
中科院分区:
医学2区
文献类型:
--
作者:
Profita, Mirella;Bonanno, Anna;Gjomarkaj, Mark

文献摘要

被引文献

相似文献

目的:乙酰胆碱(Acetylcholine,ACh)是由胆碱乙酰转移酶(Choline Acetyl-Transferase,ChAT)合成的,ChAT通过激活毒蕈碱受体(Muscarinic Receptor,MR)发挥其在气道上皮细胞中的生理作用。我们评估ACh刺激对人支气管上皮细胞(16-HBE)的影响,并测试香烟烟雾提取物(CSE)是否可以改变对ACh的基础细胞反应,从而影响非神经元胆碱能系统signaling.Main方法:ACh刺激的16-HBE进行ACh结合测试。白三烯B-4(LTB 4)释放和ERK 1/2和NF κ B通路激活。此外,我们研究了所有上述参数以及ChAT和MR蛋白和mRNA的表达和内源性ACh的生产在CSE处理16-HBE.Key结果:我们表明,ACh诱导16-HBE,in浓度依赖性的方式,LTB 4的释放通过激活ERK 1/2和NF κ B途径。添加噻托溴铵(思力华(R))、没食子胺、替仑西平和4-DAMP(毒蕈碱受体拮抗剂)以及PD 098059(MAPKK抑制剂)和BAY 117082(1 kB α磷酸化抑制剂)可下调乙酰胆碱诱导的效应。此外,CSE处理16-HBE增加了ACh的结合,并将LTB 4的释放从ACh浓度1 μ M转移到10 nM。最后,我们观察到用CSE处理16-HBE增加了ChAT、M-2和M-3的表达以及16-HBE中内源性ACh的产生。噻托溴铵可调节CSE处理的16-HBE中LTB 4的释放和ACh的产生。意义:CSE通过影响ChAT和MRS的表达,增强人支气管上皮细胞的促炎活性,促进细胞对低浓度ACh的反应。噻托溴铵可能阻止ACh与CSE共同产生的促炎事件。(C)2011 Elsevier Inc. All rights reserved.
Aims: Acetylcholine (ACh) is synthesized by Choline Acetyl-Transferase (ChAT) that exerts its physiological effects in airway epithelial cells via muscarinic receptor (MR) activation. We evaluate the effect of ACh stimulation on human bronchial epithelial cells (16-HBE) and test whether cigarette smoke extract (CSE) can modify the basal cellular response to ACh affecting the non-neuronal cholinergic system signalling.Main methods: ACh stimulated 16-HBE were tested for ACh-binding. Leukotriene B-4 (LTB4) release and ERK1/2 and NFkB pathway activation. Additionally, we investigated all the aforementioned parameters as well as ChAT and MR proteins and mRNA expression and endogenous ACh production in CSE-treated 16-HBE.Key findings: We showed that ACh induced in 16-HBE, in a concentration-dependent manner, LTB4 release via the activation of ERK1/2 and NFkB pathways. The addition of Tiotropium (Spiriva (R)), Gallamine, Telenzepine and 4-DAMP (muscarinic receptor antagonists), as well as of PD 098059 (MAPKK inhibitor) and BAY117082 (inhibitor of 1kB alpha phosphorilation), down-regulated the ACh-induced effects. Additionally, CSE treatment of 16-HBE increased the binding of ACh, and shifted the LTB4 release from the concentration ACh 1 mu M to 10 nM. Finally, we observed that the treatment of 16-HBE with CSE increased the expression of ChAT, M-2 and M-3 and of endogenous ACh production in 16-HBE. Tiotropium regulated the LTB4 release and ACh production in CSE treated 16-HBE.Significance: CSE increases the pro-inflammatory activity of human bronchial epithelial cells, and promotes the cellular response to lower concentrations of ACh, by affecting the expression of ChAT and MRs. Tiotropium might prevent pro-inflammatory events generated by ACh together with CSE. (C) 2011 Elsevier Inc. All rights reserved.